Scrip 100 Analysis: Impairment, Youth Boost R&D Spending

 
• By John Hodgson

Spending on R&D increased substantially in 2016; but the picture is complicated and more than half of the increase is due to accountancy updates following drug program failures, one large company's commitment to new projects, and young companies fuelled by generous financial markets.

Research funding
Pharma R&D spending increased in 2016 but here is the whole picture • Source: Shutterstock

More from Earnings

More from Business